Growing GLP-1 adoption could put $30 billion to $55 billion in annual food and beverage industry sales at risk by 2030, as appetite-suppressing medications reshape consumer eating habits.
20% Free Customization ON ALL PURCHASE
*Terms & Conditions Apply